EFFICACY OF MELATONIN IN MANAGEMENT OF HYPOXIC ISCHEMIC ENCEPHALOPATHY (HIE) IN NEONATES
Status:
ACTIVE_NOT_RECRUITING
Trial end date:
2026-05-10
Target enrollment:
Participant gender:
Summary
To compare the survival rate and improvement in stage of hypoxic ischemic encephalopathy (HIE) at day 7 of treatment in neonates treated with versus without melatonin in addition to standard supportive therapy.
Phase:
PHASE2
Details
Lead Sponsor:
University of Child Health Sciences and Children's Hospital, Lahore